SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of earliest event reported: January 12, 2004
Select Medical Corporation | ||
(Exact name of registrant as specified in charter) |
Delaware | 000-32499 | 23-2872718 | ||
(State of Incorporation) | (Commission File Number) | (I.R.S. Employer | ||
Identification No.) |
4716 Old Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA 17055 | ||
(Address of Principal Executive Offices) (Zip Code) |
(717) 972-1100 | ||
(Registrants telephone number, including area code) |
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. | ||||||||
Item 9. Regulation FD Disclosure. | ||||||||
SIGNATURE | ||||||||
EXHIBIT INDEX | ||||||||
INVESTOR PRESENTATION, JANUARY 2004. |
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) | Exhibits |
99.1 |
Select Medical Corporation Investor Presentation dated January 2004. |
Item 9. Regulation FD Disclosure.
Attached as exhibit 99.1 and furnished for purposes of Regulation FD is an Investor Presentation that will be given by Select Medical Corporation at the JPMorgan 22nd Annual Healthcare Conference to be held January 12-15, 2004.
The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 9 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 (the Exchange Act) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SELECT MEDICAL CORPORATION | ||||
Date: January 9, 2004 | By: | /s/ Michael E. Tarvin | ||
Michael E. Tarvin Senior Vice President, General Counsel and Secretary |
EXHIBIT INDEX
Exhibit No. | Description | |
99.1 | Select Medical Corporation Investor Presentation dated January 2004. |